Abstract | OBJECTIVE: DESIGN: Case report. SETTING: Community hospital. PATIENT(S): A 30-year-old primigravida women exposed to methotrexate (50 mg/m(2)) at 5 6/7 weeks' gestation. INTERVENTION(S): MAIN OUTCOME MEASURE(S): RESULT(S): CONCLUSION(S): As medical management of ectopic pregnancy becomes more common, practitioners should be cautious about the potential teratogenic effects in unrecognized intrauterine pregnancies and be able to diagnose the myriad defects, including cardiac anomalies, that could result from such exposure.
|
Authors | Sarah H Poggi, Alessandro Ghidini |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 96
Issue 3
Pg. 669-71
(Sep 2011)
ISSN: 1556-5653 [Electronic] United States |
PMID | 21733506
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Abortifacient Agents, Nonsteroidal
- Teratogens
- Methotrexate
|
Topics |
- Abnormalities, Multiple
(chemically induced)
- Abortifacient Agents, Nonsteroidal
(adverse effects)
- Adult
- Diagnostic Errors
- Female
- Fetal Death
- Fetal Diseases
(chemically induced)
- Humans
- Methotrexate
(adverse effects)
- Pregnancy
- Pregnancy, Ectopic
(diagnosis, drug therapy)
- Single Umbilical Artery
(chemically induced)
- Teratogens
(toxicity)
- Tetralogy of Fallot
(chemically induced)
|